Why the study?
Does combined flecainide and digoxin therapy improve conversion to sinus rhythm in fetuses with supraventricular tachycardia?
Population
20 fetuses with supraventricular tachycardia with 1:1 atrioventricular conduction ranging between 215 and…
Design
Cohort
Authors
Loading...
May support combined flecainide-digoxin for fetal SVT conversion; leaves open need for RCTs to confirm efficacy.
Does combined flecainide and digoxin therapy improve conversion to sinus rhythm in fetuses with supraventricular tachycardia?
Flecainide combined with digoxin is an effective intrauterine treatment for fetal supraventricular tachycardia, though conversion to sinus rhythm may take up to 14 days.
Krapp et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: